Xinyoukang Pharmaceutical Technology (Nanjing) Co., Ltd., established on 2018-10-19, Business scope includes medical research and experimental development(Does not contain human stem cells,Development and application of genetic diagnosis and treatment technology);Biopharmaceutical Manufacturing,Sanitary materials and medical supplies manufacturing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zensun (Shanghai) Sci & Tech Co., Ltd. is a biopharmaceutical company focusing on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs. They discover new medicines using novel disease specific targets and innovative technologies. The patented discoveries are then developed into therapies. With adherence to the tenet of “healing for life”, we hope to transform the lives of heart failure and cancer patients by providing them with drugs that treat their disease and not the symptoms. Zensun’s current pipeline covers cardiovascular disease treatment, anti-cancer drugs, and treatments for energy metabolism disorders.

Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL.

Zhuhai Yuanzhi Health Technology Co., Ltd., established on 2019-01-31, The business scope includes the business scope recorded in the articles of association:medicine,food,cosmetic,Biological product,Research and Development of Medical Devices,production and sales;technical consulting,Technical Training,technology transfer,Technical Services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Jingruikang Molecular Medicine Technology Co., Ltd., established on 2018-08-17, Business scope includes licensed projects:Inspection and testing service;Certification Services;Production of Class II Medical Devices;pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Intellectual Property Services;Conference and Exhibition Services;Non-residential real estate leases;property management;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Data processing and storage support services;Information Technology Consulting Services;software development;Optical Instrument Sales;Optical Instrument Manufacturing;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Instrument sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Production of Class I Medical Devices;Instrument Manufacturing;Entrepreneurial Space Services;business management;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Part of Changchun High & New Technology Industries (Group), Inc., Changchun Genescience Pharmaceuticals Co., Ltd. is a Chinese company located in Changchun. The firm manufactures pharmaceuticals products. It was founded in 1997. Lei Jin is the current CEO of the firm.

Yunnan Institute of Materia Medica, part of Yunnan Baiyao Group Co., Ltd., is a company headquartered in Kunming, China. The firm manufactures and distributes pharmaceutical drugs. Yunnan Baiyao Group Co., Ltd. acquired Yunnan Institute of Materia Medica from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million.

Suzhou Yongxin Biotechnology Co., Ltd., established on 2020-03-16, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Chemical product sales(No licensed chemical products);Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hunan Fenghui Biotechnology Co., Ltd., established on 2016-03-17, Business scope includes biotechnology extension services;Biological product,biological reagent,Cosmetic production;medical diagnosis,Monitoring and treatment equipment,Medical supplies and equipment retail;Class I medical device,Biological product,Class II medical device,cosmetic,Class III Medical Devices,Medical Laboratory Equipment and Appliance Sales;Class I medical device,Biological product,medicine,Class II medical device,Class III Medical Devices,cosmetic,Class II:6840In vitro diagnostic reagent development;Medical device technology promotion service;Biological resources,Stem cell and immune cell storage and biotransformation medical technology services;Development of medical testing technology;Medical laboratory technical service;Science and Technology Information Consulting Services;medical information,Technical Advisory Services;medical diagnosis,Monitoring and treatment equipment wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Rongxiang Regenerative Medicine Research Institute Co., Ltd., established on 2002-02-01, The business scope includes human stem cell in situ tissue and organ regeneration replication technology and product development,technical consulting,Technical Training,Technical Services;Production of functional cosmetics;Sell ​​self-produced products;Provide transfer of self-developed technology;Agent import and export,Import and export,Technology Import and Export;Lease of own industrial premises;Conference Services;Undertake exhibition and display activities.(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Hebei Yiling Pharmaceutical Research Institute Co., Ltd., established on 2001-04-19, Business scope includes Chinese patent medicine,Medicine and health products,Traditional Medical Devices,Western medicine,Biological product,Research and Development of Sanitary Dressing;technical consulting,Serve,transfer.(Those requiring special approval shall not operate without approval)

Shanghai Youshen Biotechnology Co., Ltd., established on 2014-06-09, The scope of business includes engaging in technology development in the field of biotechnology,technical consulting,Business Consulting(In addition to brokerage),Instrumentation,laboratory equipment(except medical devices),chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian firecrackers,precursor chemicals),IClass medical device sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Beijing Ethel Biomedical Research Co., Ltd., established on 2014-07-18, Business scope includes medical research and experimental development;technology development;technical consulting;Technical Services;technology transfer.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Jiangsu Qi's Biotechnology Co., Ltd., established on 2009-12-16, Business scope includes biopharmaceutical reagents,Research on New Drug Diagnostic Reagents,to develop,Technical Services;R&D and application of cell technology and cell products,technical consulting,technology transfer,Technical Services;Stem Cell and Immune Cell Banking Services;biopharmaceuticals(Does not contain dangerous goods)promotion of;Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Yusen Biotechnology Co., Ltd., established on 2003-08-01, Business scope includes general items:Engaged in technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,Exhibition display service,Scientific reagents,Sales of laboratory equipment and consumables;Sales of Class I Medical Devices;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Jiangsu Kanion Pharma is a pharmaceuticals company based out of LIANYUNGANG. Jiangsu Kanion Pharma representatives, don’t miss out on opportunities to build relationships with members on LinkedIn. Claim your page, write a simple description, and share content to attract followers that can lead to new customers, brand fans, and future employees.

Tianchang Yifan Pharmaceutical Co., Ltd., established on 1997-01-31, The business scope includes small volume injections,tablet,hard capsule,Granules,oral liquid,mixture,Pills,Solution(external use)(Operate with a valid license);Sanitary products(anti-(suppress)Bacterial preparation(liquid),(purify))development and production(Operate with a valid license);Acquisition of agricultural and sideline products of animal and plant medicinal materials(Except those involving pre-approval),Operating the export business of the company's self-produced products and related technologies(Except for the goods and technologies that the state restricts the company to operate and prohibits import and export);Operate the production of the enterprise,Raw and auxiliary materials required for scientific research,Equipment,Instrumentation and parts(Except for the goods operated by the company approved by the state);Operating the enterprise's processing with imported materials and"Three to one make up"business[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Xi'an Qinshen Jiahe Pharmaceutical Research Co., Ltd., established on 2018-11-06, Business scope includes research and development of pharmaceutical and health products;drug research,to develop,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd., a subsidiary of Tianjin Zhongxin Pharmaceutical Group Corp. Ltd., is a company headquartered in Tianjin, China. The firm engages in Chinese traditional medicines production.